OPTIMIZATION OF HCV CELL CULTURE SYSTEM FOR EVALUATION OF ANTIVIRAL DRUGS AGAINST HCV GENOTYPES 2a AND 4a

Area of Science:

• Virology
• Cell Biology
• Drug Discovery

Background:

• Hepatitis C virus (HCV) cell culture is crucial for understanding viral replication and developing antiviral therapies.
• Existing cell culture systems facilitate the study of HCV genotypes and their global spread.

Purpose of the Study:

• To establish and validate a hepatitis C virus (HCV) cell culture system for evaluating antiviral compound efficacy.
• To demonstrate the utility of this system for both qualitative and quantitative assessment of antiviral activity.

Main Methods:

• HCV RNA synthesis via in vitro transcription of JFH1 (genotype 2a) and ED43/C-NS2/NS5A (genotype 4a) plasmids.
• Transfection of Huh7.5 cells with synthesized RNA to generate infectious HCV particles.
• Infection of Huh7.5 cells, followed by immunostaining for infection confirmation and real-time PCR for viral load quantification.

Main Results:

• Successful generation and infection of Huh7.5 cells with HCV genotypes 2a and 4a, confirmed by green fluorescence.
• Quantification of viral load in infected cells, showing 32,500 copies/mL for genotype 2a and 107,375 copies/mL for genotype 4a.
• Demonstrated the system's capability to distinguish antiviral effectiveness against both genotypes.

Conclusions:

• The developed HCV cell culture system provides a reliable platform for evaluating antiviral agents.
• This model system is effective for both qualitative and quantitative assessment of drug efficacy against diverse HCV genotypes.
• Facilitates the discovery of more potent antiviral compounds and aids in understanding HCV pathogenesis.